21-1657 • July 23, 2019
Class Period Start
March 2, 2017
Class Period End
February 22, 2019
PSLRA Deadline
September 23, 2019
Case Allegations
10b5 + Sec11
10b-5 Statutes of Repose
Mar 2, 2020
Sec11 Statutes of Repose
Apr 28, 2020
Country
United States
Court
Federal Court
Aug 5, 2022
Aug 24, 2021
Jul 21, 2021
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Nov 2, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Oct 22, 2020
A new complaint has been filed on behalf of certain investors in Karyopharm Therapeutics Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Oct 16, 2020
Jul 31, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jun 29, 2020
A new complaint has been filed on behalf of certain investors in Karyopharm Therapeutics Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
May 14, 2020
Apr 29, 2020
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Mar 12, 2020
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Sep 17, 2019
Another plaintiff has filed a complaint on behalf of investors in Karyopharm Therapeutics Inc.. The allegations and class definitions are substantively the same.
Jul 23, 2019
A securities fraud class action complaint has been filed on behalf of certain investors in Karyopharm Therapeutics Inc..
TOP
